Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001127362 | SCV001286669 | uncertain significance | Osteogenesis imperfecta | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127363 | SCV001286670 | uncertain significance | Infantile cortical hyperostosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001127364 | SCV001286671 | benign | Ehlers-Danlos syndrome, arthrochalasia type | 2017-05-22 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV001856661 | SCV002132830 | benign | Osteogenesis imperfecta type I | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002276632 | SCV002565524 | uncertain significance | Ehlers-Danlos syndrome | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348571 | SCV002622190 | uncertain significance | Cardiovascular phenotype | 2023-08-07 | criteria provided, single submitter | clinical testing | The p.R1252H variant (also known as c.3755G>A), located in coding exon 48 of the COL1A1 gene, results from a G to A substitution at nucleotide position 3755. The arginine at codon 1252 is replaced by histidine, an amino acid with highly similar properties. In one study, this variant co-occurred with a complex rearrangement reportedly resulting in complete allelic loss of COL3A1 and COL5A2 in an individual with suspected vascular Ehlers-Danlos syndrome (Weerakkody RA et al. Genet. Med., 2016 11;18:1119-1127). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV003222227 | SCV003918266 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Not located in the triple helical region, where the majority of pathogenic missense variants occur (HGMD) |